Optimizerx Corp key statistics and ratios
In fiscal 2025, Optimizerx Corp had return on equity of 4.2%, an operating margin of 10.7%, debt equal to 20.5% of equity and a current ratio of 3.04. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 94.2% | 60.2% | 50.5% | 49.8% | 56.0% | 49.1% | 57.6% | 62.8% | 55.7% | 58.1% | 62.4% | 60.0% | 64.5% | 67.3% | 73.2% |
| Operating margin | <−999% | −130.8% | −22.9% | −5.7% | −15.8% | −8.3% | −20.4% | −17.6% | 0.8% | −15.0% | −4.9% | 0.6% | −19.7% | −36.9% | −14.9% | 10.7% | 11.1% |
| Net margin | <−999% | −190.8% | −22.9% | −5.7% | −15.8% | −8.2% | −19.9% | −17.3% | 1.1% | −12.8% | −5.1% | 0.6% | −18.3% | −24.6% | −21.8% | 4.7% | 4.7% |
| Free-cash-flow margin | <−999% | −48.1% | −31.5% | 24.2% | −1.0% | 7.1% | −8.3% | −12.6% | 3.6% | −7.1% | −14.7% | 1.0% | 16.9% | −10.2% | 5.2% | 17.0% | 18.6% |
| Return on equity | −106.1% | −121.8% | −30.4% | −17.4% | −32.7% | −8.8% | −18.4% | −30.0% | 1.8% | −9.9% | −4.7% | 0.4% | −8.9% | −13.9% | −16.5% | 4.2% | 3.5% |
| Return on assets | −53.6% | −63.9% | −17.9% | −8.7% | −18.7% | −6.2% | −12.9% | −19.8% | 1.3% | −7.7% | −3.8% | 0.4% | −8.3% | −11.0% | −11.3% | 2.9% | 2.7% |
| Asset turnover | 0.02 | 0.33 | 0.79 | 1.53 | 1.18 | 0.75 | 0.65 | 1.14 | 1.22 | 0.60 | 0.74 | 0.61 | 0.45 | 0.45 | 0.52 | 0.63 | 0.58 |
| Current ratio | 2.44 | 1.19 | 1.26 | 1.16 | 2.31 | 3.30 | 2.78 | 2.49 | 3.72 | 4.44 | 3.28 | 12.29 | 11.74 | 3.04 | 2.89 | 3.04 | 5.58 |
| Debt to equity | 52.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 30.3% | 29.3% | 20.5% | 15.0% |
| Interest cover (operating income ÷ interest) | — | n/m | n/m | — | — | — | — | — | — | — | — | — | — | n/m | n/m | 2.2x | 2.3x |
| Effective tax rate | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.2% | 32.1% |
| R&D as % of revenue | — | — | — | — | — | — | — | — | 0.0% | 6.5% | 0.0% | — | — | — | 0.0% | 0.0% | — |
| SG&A as % of revenue | — | — | — | — | — | — | — | — | — | — | — | 45.2% | 53.6% | — | — | — | — |
| Capital spending as % of revenue | −1.7% | 1.2% | 0.1% | 0.0% | 0.1% | 0.0% | 2.3% | 0.3% | 0.2% | 0.4% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Free cash flow ÷ net income | — | — | — | — | — | — | — | — | 335.0% | — | — | 165.5% | — | — | — | 363.5% | 399.0% |
| Dividends and buybacks ÷ free cash flow | — | — | — | 0.0% | — | 0.0% | — | — | — | — | — | — | 189.4% | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.1% | 68.1% | 60.9% | 63.8% | 67.2% | 74.8% | 75.2% | 76.5% |
| Operating margin | −40.2% | 11.2% | −9.6% | 11.0% | 7.9% | 26.6% | 2.0% | −0.4% |
| Net margin | −42.8% | −0.2% | −10.0% | 5.2% | 3.0% | 15.6% | −2.5% | −3.4% |
| Free-cash-flow margin | 8.3% | 0.6% | 17.5% | 15.6% | 12.2% | 22.0% | −2.5% | 41.8% |
| Current ratio | 3.23 | 2.89 | 2.82 | 2.57 | 3.05 | 3.04 | 5.37 | 5.58 |
| Debt to equity | 30.8% | 28.0% | 27.9% | 23.8% | 23.0% | 20.0% | 18.0% | 14.5% |
| R&D as % of revenue | — | — | 14.8% | 10.6% | — | — | 17.1% | 16.0% |
Financial health
- Short-term assets cover short-term liabilities $54m of assets due within a year against $10m of liabilities due within a year.
- Short-term assets cover long-term liabilities $54m short-term assets against $24m of longer-dated liabilities.
- More cash than debt $24m of cash against $19m of debt.
- Debt below 40% of shareholders' equity Debt is 15% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $18m of operating cash flow against $19m of debt.
- Operating profit covers interest at least five times over Operating income of $11m against $5m of interest.
Moat
Weak moat
How hard Optimizerx's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Net income has been a median -5.3% of total assets over 10 years.
- Pricing power 16 / 20
Gross margin has been a median 60.2%, moving by 6.0 percentage points (standard deviation) across 10 years.
- Durability 10 / 20
Operating margin has been a median -7.9%; its worst year was -27.9%.
- Cash conversion 6 / 20
Free cash flow was positive in 5 of 10 years, at a median 1.6% of revenue.
- Discipline 2 / 20
The diluted share count rose 18.4% over five years; stock-based pay has been a median 8.9% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (34 before it).
Compare with peers
- Sophia Genetics SA statistics
- Carecloud, Inc. statistics
- American Well Corp statistics
- Definitive Healthcare Corp. statistics
- Health Catalyst, Inc. statistics
Head to head: OPRX vs SOPHCCLD vs OPRXAMWL vs OPRX
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies